Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy

Table 4

The outcome of calcific uremic arteriolopathy lesions in relation to the severity of hyperparathyroidism, levels of calcium-phosphate products, the degree of hyperphosphatemia, and the timing of the diagnosis.

Outcome	Parathyroid hormone levels				value
		<600	>/=600	Total
	Improved	7 (70%)	3 (30%)	10 (100%)	0.79
	Partial improvement	1 (50.00%)	1 (50.00%)	2 (100%)
	Expired or amputation	7 (58.3%)	5 (41.7%)	12 (100%)
Total		15	9	24
Outcome	Calcium-phosphate product levels
		<55	>/=55	Total
	Improved	7 (70%)	3 (30%)	10 (100%)	0.18
	Partial improvement	2 (100%)	0 (0.00%)	2 (100%)
	Expired/Amputated	5 (41.7%)	7 (58.3%)	12 (100%)
Total		14	10	24
Outcome	Phosphate levels
		<6.5	>6.5	Total
	Improved	8 (80%)	2 (20%)	10 (100%)	0.94
	Partial improvement	2 (100%)	0 (0.00%)	2 (100%)
	Expired/Amputated	5 (41.7%)	7 (58.3%)	12 (100%)
Total		15	9	24 (100%)
Outcome	Timing of diagnosis
		Early	Late	Total
	Improved	7 (70%)	3 (30%)	10 (100%)	0.019
	Partial improvement	0 (0.00%)	2 (100%)	2 (100%)
	Expired/Amputated	2 (16.7%)	10 (83.3%)	12(100%)
Total		9 (37.5%)	15 (62.5%)	24 (100%)